MD Anderson is conducting a clinical trial to explore a cord blood expansion technology called ‘Co-culture’. Cord blood is a valuable, non-controversial source of stem cells with effect
This international, multicenter, open-label clinical trial is sponsored by Merck & Co and is part of the Vantage program. The trial will enroll 142 patients from more than
Proceeds from the financing will be used to advance multiple transient receptor potential (TRP) ion channel drug programs, with the most advanced program moving toward clinical trials in
The agreements enable global travelers covered by HTH’s international health insurance programs to arrange convenient appointments for diagnostic and treatment services and to have the clinics bill HTH
In December 2007, GSK and Galapagos initiated a program to discover and develop novel anti-infective drug candidates for GSK’s Infectious Diseases Centre of Excellence in Drug Discovery (ID
deCODEme Cardio detects genetic risk factors for heart attack, stroke and atrial fibrillation, peripheral artery disease (PAD) and several other conditions. deCODEme Cancer measures genetic risk factors for
RiaSTAP is not indicated to treat dysfibrinogenemia. Approval was based on a pivotal Phase II prospective, open-label pharmacokinetic (PK) and safety study using maximum clot firmness (MCF) as
“The potential applications of magnetic sensor technology for future medical devices are nothing short of profound,” said Steven Van Fleet, president of (MASTInc). “Imagine a wristwatch-sized device that
These funds, which bear no interest, become repayable on the commercialization of C-Cure. The new funds, which have come from a range of new and existing investors, will
Before joining KineMatik, Mr Jarjour was vice president of global marketing at Organon. Previously, Mr Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.